SCHEMBL1504830

SCHEMBL1504830

COC(=O)[C@H](CNC(=O)OC(C)(C)C)N1CCN(S(=O)(=O)c2ccc(C)cc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.48
ADAM17 P78536 1/20 0.47
LMNA P02545 2/20 0.47
GAA P10253 1/20 0.47
PKM P14618 4/20 0.46
NPSR1 Q6W5P4 1/20 0.45
ALDH1A1 P00352 4/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
MDM2 Q00987 1/20 0.44
USP2 O75604 1/20 0.44
POLB P06746 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
F13A1 P00488 1/20 0.42
TGM2 P21980 1/20 0.42
TGM1 P22735 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1504592 0.91 KDM4E (0.52) KDM4EADAM17LMNAGAAPKM
SCHEMBL10276471 0.91 KDM4E (0.52) KDM4EADAM17LMNAGAAPKM
SCHEMBL1504710 0.81 ADAM17 (0.45) ADAM17ALDH1A1
SCHEMBL1504673 0.81 ADAM17 (0.45) ADAM17ALDH1A1
SCHEMBL1504961 0.80 KDM4E (0.56) KDM4ELMNAGAAPKMNPSR1
SCHEMBL18289813 0.77 GAA (0.60) KDM4ELMNAGAAPKMALDH1A1
SCHEMBL2681098 0.76 L3MBTL1 (0.40) KDM4ELMNAGAAALDH1A1KMT2A
SCHEMBL1503589 0.75 L3MBTL1 (0.39) LMNAGAAALDH1A1KMT2AMEN1
SCHEMBL10079851 0.75 L3MBTL1 (0.39) LMNAGAAALDH1A1KMT2AMEN1
SCHEMBL5489489 0.75 MAPK1 (0.50) KDM4EGAAALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011033009-A1 N- [2-HYDROXYCARBAMOYL-2- (PIPERAZINYL) ETHYL] BENZAMIDE COMPOUNDS, THEIR PREPARATION AND THEIR USE AS TACE INHIBITORS GALDERMA RESEARCH & DEVELOPMENT (FR) 2011-03-24 WO disclosed